Bank of New York Mellon’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-258,356
| Closed | -$17.5M | – | 4296 |
|
|
2019
Q3 | $17.5M | Buy |
258,356
+149,238
| +137% | +$10.2M | ﹤0.01% | 1611 |
|
|
2019
Q2 | $6.35M | Buy |
109,118
+7,223
| +7% | +$428K | ﹤0.01% | 2208 |
|
|
2019
Q1 | $7.14M | Sell |
101,895
-7,721
| -7% | -$573K | ﹤0.01% | 2159 |
|
|
2018
Q4 | $7.06M | Sell |
109,616
-1,194
| -1% | -$83.7K | ﹤0.01% | 2096 |
|
|
2018
Q3 | $7.78M | Sell |
110,810
-11,436
| -9% | -$669K | ﹤0.01% | 2172 |
|
|
2018
Q2 | $6.16M | Buy |
122,246
+28,710
| +31% | +$1.14M | ﹤0.01% | 2283 |
|
|
2018
Q1 | $2.93M | Buy |
93,536
+2,392
| +3% | +$79.4K | ﹤0.01% | 2618 |
|
|
2017
Q4 | $3.12M | Buy |
91,144
+564
| +0.6% | +$18K | ﹤0.01% | 2590 |
|
|
2017
Q3 | $2.91M | Buy |
90,580
+866
| +1% | +$27.3K | ﹤0.01% | 2609 |
|
|
2017
Q2 | $2.92M | Buy |
89,714
+1,137
| +1% | +$36K | ﹤0.01% | 2615 |
|
|
2017
Q1 | $2.79M | Buy |
88,577
+500
| +0.6% | +$14.8K | ﹤0.01% | 2647 |
|
|
2016
Q4 | $2.59M | Buy |
88,077
+2,039
| +2% | +$62.2K | ﹤0.01% | 2696 |
|
|
2016
Q3 | $2.49M | Sell |
86,038
-2,925
| -3% | -$81.5K | ﹤0.01% | 2630 |
|
|
2016
Q2 | $2.3M | Buy |
88,963
+2,315
| +3% | +$61.5K | ﹤0.01% | 2626 |
|
|
2016
Q1 | $2.15M | Buy |
86,648
+5,157
| +6% | +$142K | ﹤0.01% | 2616 |
|
|
2015
Q4 | $2.87M | Sell |
81,491
-1,528
| -2% | -$40.9K | ﹤0.01% | 2508 |
|
|
2015
Q3 | $1.76M | Sell |
83,019
-16,357
| -16% | -$422K | ﹤0.01% | 2818 |
|
|
2015
Q2 | $2.76M | Buy |
99,376
+8,454
| +9% | +$238K | ﹤0.01% | 2705 |
|
|
2015
Q1 | $2.78M | Buy |
90,922
+405
| +0.4% | +$12.9K | ﹤0.01% | 2646 |
|
|
2014
Q4 | $2.89M | Sell |
90,517
-2,739
| -3% | -$89.1K | ﹤0.01% | 2618 |
|
|
2014
Q3 | $2.64M | Buy |
93,256
+6,239
| +7% | +$174K | ﹤0.01% | 2688 |
|
|
2014
Q2 | $2.38M | Sell |
87,017
-1,407
| -2% | -$37.5K | ﹤0.01% | 2797 |
|
|
2014
Q1 | $2.33M | Sell |
88,424
-17,952
| -17% | -$515K | ﹤0.01% | 2785 |
|
|
2013
Q4 | $3.11M | Buy |
106,376
+14,283
| +16% | +$453K | ﹤0.01% | 2603 |
|
|
2013
Q3 | $2.82M | Buy |
92,093
+574
| +0.6% | +$19.2K | ﹤0.01% | 2614 |
|
|
2013
Q2 | $2.9M | Buy |
+91,519
| New | +$3.01M | ﹤0.01% | 2543 |
|
Bank of New York Mellon's GHDX Position: Q4 2019 in Review
Bank of New York Mellon sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 258,356 shares — an estimated $17.5M sold.
Bank of New York Mellon first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $17.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Bank of New York Mellon reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Bank of New York Mellon sold 258,356 Genomic Health, Inc. shares in Q4 2019, an estimated $17.5M.
- Bank of New York Mellon first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Bank of New York Mellon's Genomic Health, Inc. position peaked at $17.5M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.